← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 1, 2011Last known activity
Dec 31, 2020
Defunct as of Dec 31, 2025
Timeline
2000s
- Jan 1, 2003
Catalyst Biosciences— Founded
2010s
- Jan 1, 2015
Targacept— Acquired
2020s
- Dec 31, 2025
Catalyst Biosciences— Defunct
Drugs by trial phase (12 distinct, 28 trials)
Phase 3 (1 own, 1 via acquisition)
Phase 2 (1 own, 7 via acquisition)
Phase 1 (1 own, 1 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (8)
- NCT04548791Lead sponsorPhase 1/Phase 2Dec 31, 2020
- NCT04489537Lead sponsorPhase 3Nov 30, 2020
- NCT04072237Lead sponsorPhase 1Sep 30, 2019
- NCT03995784Study directorPhase 2Jun 18, 2019
- NCT03995784Lead sponsorPhase 2Jun 18, 2019
- NCT03407651Lead sponsorPhase 2Dec 18, 2017
- NCT03407651Study directorPhase 2Dec 18, 2017
- NCT01439971Lead sponsorPhase 1Dec 1, 2011
Details
- Founded
- South San Francisco, CA, US Jan 1, 2003
- Last known activity
- Dec 31, 2020